Lee, E. Q., Muzikansky, A., Duda, D. G., Gaffey, S., Dietrich, J., Nayak, L., . . . Wen, P. Y. (2019). Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma. Cancer Med.
Citação norma ChicagoLee, Eudocia Q., et al. "Phase II Trial of Ponatinib in Patients With Bevacizumab‐refractory Glioblastoma." Cancer Med 2019.
MLA citiranjeLee, Eudocia Q., et al. "Phase II Trial of Ponatinib in Patients With Bevacizumab‐refractory Glioblastoma." Cancer Med 2019.
Opozorilo: Ti citati niso vedno 100% točni.